Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1078-1084

  Starkey, C R ^a   Lobelle Rich, P A ^a   Granger, S ^b   Brightman, B K ^b   Fan, H ^b   Levy, L S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; DNA SEQUENCE; FELINE LEUKEMIA VIRUS; LONG TERMINAL REPEAT; LYMPHOMA; MURINE LEUKEMIA VIRUS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RETROVIRUS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS INFECTIVITY; VIRUS RECOMBINANT;

EID: 0031951160     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1078-1084.1998     Document Type: Article

References (43)

1. Athas, G., B. Choi, S. Prabhu, P. Lobelle-Rich, and L. S. Levy. 1995. Genetic determinants of feline leukemia virus-induced multicentric lymphomas. Virology 214:431-438.
2. Athas, G., P. Lobelle-Rich, and L. S. Levy. 1995. Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors. J. Virol. 69:3324-3332.
3. Athas, G., C. Starkey, and L. S. Levy. 1994. Retroviral determinants of leukemogenesis. Crit. Rev. Oncog. 5:169-199.
4. Belli, B., and H. Fan. 1994. The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation. J. Virol. 68:6883-6889.
5. Belli, B., A. Patel, and H. Fan. 1995. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation. J. Virol. 69:1037-1043.
6. Bonham, L., P. A. Lobelle-Rich, L. A. Henderson, and L. S. Levy. 1987. Transforming potential of a myc-containing variant of feline leukemia virus in vitro in early-passage feline cells. J. Virol. 61:3072-3081.
7. Boral, A. L., S. A. Okenquist, and J. Lenz. 1989. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element. J. Virol. 63:76-78.
8. Bösze, Z., H.-J. Thiesen, and P. Charnay. 1986. A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus. EMBO J. 5:1615-1623.
9. Brightman, B. K., K. G. Chandy, R. H. Spencer, S. Gupta, P. K. Pattengale, and H. Fan. 1988. Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. J. Immunol. 141:2844-2854.
10. Brightman, B. K., B. R. Davis, and H. Fan. 1990. Preleukemic hematopoietic hyperplasia induced by Moloney murine leukemia virus is an indirect consequence of viral infection. J. Virol. 64:4582-4584.
11. Brightman, B. K., C. Farmer, and H. Fan. 1993. Escape from in vivo restriction of Moloney mink cell locus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations. J. Virol. 67:7140-7148.
12. Brightman, B. K., A. Rein, D. J. Trepp, and H. Fan. 1991. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo. Proc. Natl. Acad. Sci. USA 88:2264-2268.
13. Chatis, P. A., C. A. Holland, J. W. Hartley, W. P. Rowe, and N. Hopkins. 1983. Role for the 3′ end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Proc. Natl. Acad. Sci. USA 80:4408-4411.
14. Chatis, P. A., C. A. Holland, J. E. Silver, T. N. Frederickson, N. Hopkins, and J. W. Hartley. 1984. A 3′ end fragment encompassing the transcriptional enhancers of nondcfective Friend virus confers erythroleukemogenicity on Moloney leukemia virus. J. Virol. 52:248-254.
15. Chen, H., and F. K. Yoshimura. 1994. Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities. J. Virol. 68:3308-3316.
16. Cory, S., M. Graham, E. Webb, L. Corcoran, and J. M. Adams. 1985. Variant (6:15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J. 4:675-681.
17. DesGroseillers, L., and P. Jolicoeur. 1984. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:945-952.
18. DesGroseillers, L., E. Rassart, and P. Jolicoeur. 1983. Thymotropism of murine leukemia virus is conferred by its long terminal repeat. Proc. Natl. Acad. Sci. USA 80:4203-4207.
19. Fan, H. 1997. Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol. 5:74-82.
20. Flubacher, M. M., S. E. Bear, and P. N. Tsichlis. 1994. Replacement of interleukin-2 (IL-2)-generated mitogenic signals by a mink cell focus-forming (MCF) or xenotropic virus-induced IL-9-dependent autocrine loop: implications for MCF virus-induced leukemogenesis. J. Virol. 68:7709-7716.
21. Fulton, R., M. Plumb, L. Shield, and J. C. Neil. 1990. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J. Virol. 64:1675-1682.
22. Golemis, E., Y. Li, T. N. Fredrickson, J. W. Hartley, and N. Hopkins. 1989. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses. J. Virol. 63:328-337.
23. Granger, S., B. K. Brightman, and H. Fan. Unpublished data.
24. Hedrick, S. M., D. I. Cohen, E. A. Nielsen, and M. M. Davis. 1984. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 308:149-153.
25. Holland, C. A., C. Y. Thomas, S. K. Chattopadhyay, C. Koehne, and P. V. O'Donnell. 1989. Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses. J. Virol. 63:1284-1292.
26. Lenz, J., D. Celander, R. L. Crowther, R. Patarca, D. W. Perkins, and W. A. Haseltine. 1984. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature 308:467-470.
27. Levesque, K., M.-G. Mattei, and L. S. Levy. 1991. Evolutionary conservation and chromosomal localization of flvi-1. Oncogene 6:1377-1379.
28. Levesque, K. S., L. Bonham, and L. S. Levy. 1990. flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J. Virol. 64:3455-3462.
29. Levy, L. S. Unpublished observations.
30. Li, Q. X., and H. Fan. 1990. Combined infection by Moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic mice. J. Virol. 64:3701-3711.
31. Li, Y., E. Golemis, J. W. Hartley, and N. Hopkins. 1987. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J. Virol. 61:693-700.
32. LoSardo, J. E., A. L. Boral, and J. Lenz. 1990. Relative importance of elements within the SL3-3 virus enhancer for T-cell specificity. J. Virol. 64:1756-1763.
33. Matsumoto, Y., Y. Momoi, T. Watari, R. Goitsuka, H. Tsujimoto, and A. Hasegawa. 1992. Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and non-neoplastic diseases. Virology 189:745-749.
34. Miura, T., M. Shibuya, H. Tsujimoto, M. Fukasawa, and M. Hayami. 1989. Molecular cloning of a feline leukemia provirus integrated adjacent to the c-myc gene in a feline T-cell leukemia cell line and the unique structure of its long terminal repeat. Virology 169:458-461.
35. Morrison, H. L., B. Soni, and J. Lenz. 1995. Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus. J. Virol. 69:446-455.
36. Pantginis, J., R. M. Beaty, L. S. Levy, and J. Lenz. 1997. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity. J. Virol. 71:9786-9791.
37. Rezanka, L. J., J. L. Rojko, and J. C. Neil. 1992. Feline leukemia virus: pathogenesis of neoplastic disease. Cancer Invest. 10:371-389.
38. Rohn, J. L., and J. Overbaugh. 1995. In vivo selection of long terminal repeat alterations in feline leukemia virus-induced thymic lymphomas. Virology 206:661-665.
39. Rowe, W. P., W. E. Pugh, and J. Hartley. 1970. Plaque assay techniques for murine leukemia viruses. Virology 42:1136-1139.
40. Short, M. K., S. A. Okenquist, and J. Lenz. 1987. Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeat. J. Virol. 61:1067-1072.
41. Speck, N. A., and D. Baltimore. 1987. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7:1101-1110.
42. Speck, N. A., B. Renjifo, E. Golemis, T. N. Fredrickson, J. W. Hartley, and N. Hopkins. 1990. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:233-242.
43. Yoshimura, F. K., B. Davison, and K. Chaffin. 1985. Murine leukemia virus long terminal repeat sequences can enhance gene activity in a cell-type-specific manner. Mol. Cell. Biol. 5:2832-2835.